Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 |
| | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Diagnostics | | | 593.5 | | 690.4 | 679.4 | | 695.5 |
| Other | | | 45.1 | | 53.3 | 49.3 | | 27.6 |
| Total revenues [+] | 690.6 | 557.1 | 638.6 | 851.1 | 743.7 | 728.7 | 740.5 | 723.1 |
| Services | | | | | | | | 695.5 |
| Other | | | | | | | | 27.6 |
| Revenue growth [+] | 24.0% | | -25.0% | 14.4% | 2.1% | -1.6% | 2.4% | -7.1% |
| Diagnostics | | | | | 1.6% | | | -7.0% |
| Other | | | | | 8.1% | | | -8.0% |
| Cost of goods sold | 197.6 | 276.6 | 183.3 | 201.0 | 116.0 | 170.4 | 157.3 | 132.8 |
| Gross profit | 493.0 | 280.5 | 455.3 | 650.1 | 627.7 | 558.3 | 583.2 | 590.3 |
| Gross margin | 71.4% | 50.4% | 71.3% | 76.4% | 84.4% | 76.6% | 78.8% | 81.6% |
| Selling, general and administrative | 537.8 | 496.9 | 510.1 | 556.6 | 435.0 | 439.9 | 359.2 | 366.0 |
| Research and development | 81.9 | 73.3 | 77.2 | 85.9 | 70.8 | 74.4 | 70.6 | 75.5 |
| Other operating expenses | 1.8 | | 2.8 | -1.1 | | | | 14.6 |
| EBITDA [+] | -65.7 | -218.3 | -62.8 | 81.7 | 176.3 | 92.3 | 180.2 | 159.2 |
| EBITDA growth | -69.9% | | -176.9% | -53.7% | 91.0% | -48.8% | 13.2% | -44.8% |
| EBITDA margin | -9.5% | -39.2% | -9.8% | 9.6% | 23.7% | 12.7% | 24.3% | 22.0% |
| Depreciation | 12.1 | 71.4 | 11.0 | 13.7 | 17.1 | 15.0 | 14.1 | 12.3 |
| EBITA | -77.8 | -289.7 | -73.8 | 68.0 | 159.2 | 77.3 | 166.1 | 146.9 |
| EBITA margin | -11.3% | -52.0% | -11.6% | 8.0% | 21.4% | 10.6% | 22.4% | 20.3% |
| Amortization of intangibles | 50.7 | | 61.0 | 59.3 | 37.3 | 33.3 | 12.7 | 12.7 |
| EBIT [+] | -128.5 | -289.7 | -134.8 | 8.7 | 121.9 | 44.0 | 153.4 | 134.2 |
| EBIT growth | -55.6% | | -1649.4% | -92.9% | 177.0% | -71.3% | 14.3% | -51.1% |
| EBIT margin | -18.6% | -52.0% | -21.1% | 1.0% | 16.4% | 6.0% | 20.7% | 18.6% |
| Non-recurring items | 62.0 | | 96.9 | 1.1 | | | | |
| Interest expense, net [+] | 5.9 | | 7.8 | 8.8 | 1.4 | 4.8 | -0.6 | -0.2 |
| Interest expense | 6.6 | | 10.8 | 12.0 | 3.2 | 6.0 | 0.3 | 0.2 |
| Interest income | 0.7 | | 3.0 | 3.2 | 1.8 | 1.2 | 0.9 | 0.4 |
| Other income (expense), net [+] | 139.3 | 6.1 | 16.2 | 1.2 | -0.4 | -3.0 | 2.0 | 0.5 |
| Change in value of contingent liability | | | -2.8 | | -61.2 | -0.8 | | |
| Other | 139.3 | | 16.2 | 1.2 | -0.4 | -3.0 | 2.0 | 0.5 |
| Pre-tax income | -57.1 | -283.6 | -223.3 | 0.0 | 120.1 | 36.2 | 156.0 | 134.9 |
| Income taxes | -29.9 | -59.9 | -23.7 | -4.4 | -13.0 | 19.0 | 38.8 | 54.7 |
| Tax rate | 52.4% | 21.1% | 10.6% | | | 52.5% | 24.9% | 40.5% |
| Minority interest | | -0.1 | -0.1 | -0.2 | -0.2 | -0.2 | | |
| Net income | -27.2 | -223.7 | -199.5 | 4.6 | 133.3 | 17.4 | 117.2 | 80.2 |
| Net margin | -3.9% | -40.2% | -31.2% | 0.5% | 17.9% | 2.4% | 15.8% | 11.1% |
| |
| Basic EPS [+] | ($0.35) | ($223.60) | ($2.69) | $0.06 | $1.92 | $0.25 | $1.67 | $1.12 |
| Growth | -99.8% | | -4390.3% | -96.7% | 653.9% | -84.8% | 48.8% | -51.7% |
| Diluted EPS [+] | ($0.35) | ($223.60) | ($2.69) | $0.06 | $1.85 | $0.25 | $1.60 | $1.08 |
| Growth | -99.8% | | -4536.2% | -96.7% | 632.0% | -84.2% | 48.3% | -52.2% |
| |
| Shares outstanding (basic) [+] | 78.0 | 1.0 | 74.3 | 73.5 | 69.4 | 68.3 | 70.0 | 71.3 |
| Growth | 7696.5% | | 1.1% | 5.9% | 1.6% | -2.4% | -1.8% | -5.8% |
| Shares outstanding (diluted) [+] | 78.0 | 1.0 | 74.3 | 76.0 | 72.0 | 68.8 | 73.4 | 74.5 |
| Growth | 7696.5% | | -2.2% | 5.6% | 4.7% | -6.3% | -1.5% | -4.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|